Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: Werewolf Therapeutics (HOWL)
Werewolf Therapeutics focuses on the targeted delivery of immunostimulants into tumors to minimize side effects. This quarterly EPS trend captures the market reaction, where the value of 118.80 corresponds to the current metric. Financial stability currently depends on external research funding, while the company's impeccable scientific reputation in oncology maintains a high level of investor confidence.
Rincian metrik komprehensif lan analitis Werewolf Therapeutics (HOWL)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data kapitalisasi buku:
- rincian utang lan likuiditas:
Utang marang Ekuitas Werewolf Therapeutics|HOWL - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas werewolftx.com|HOWL - Utang kumulatif perusahaan|Utang marang nilai buku Werewolf|HOWL - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan Werewolf Therapeutics|Rasio cepet werewolftx.com
- rincian bathi lan kelipatan pasar:
HOWL - Bathi pungkasan|Proyeksi bathi mangsa ngarep Werewolf Therapeutics|HOWL - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep werewolftx.com|HOWL - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Werewolf|HOWL - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Werewolf Therapeutics|HOWL - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan werewolftx.com|HOWL - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Werewolf Therapeutics
Analisis komprehensif perusahaan:Werewolf Therapeutics Inc., HOWL
Unique patents and stringent FDA oversight create colossal barriers to entry for Werewolf Therapeutics (HOWL), driving high R&D costs. The growth rate of quarterly earnings per share measures net income dynamics, smoothing the gaps between reports to assess current business momentum, which allows investors to promptly identify margin compression risks or confirm the asset's fundamental stability.
Pesaing Werewolf Therapeutics
IBRX: Wutah bathi EPS kuartalan|IMCR - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Janux Pharma|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Arcus Corp (RCUS)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Zymeworks Inc. (ZYME)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan tangotx.com TNGX|Iovance Biotherapeutics, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan Immatics NV IMTX|XNCR - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CMPX (Compass Therapeutics Corp) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Replimune Group, Inc. (REPL) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan lyell.com (LYEL)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan IPHA|PYXS - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CGEN (Compugen Ltd.)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IOBT|Wutah bathi EPS kuartalan STRO (Sutro Biopharma, Inc.)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan INKT|Immix - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan alxoncology.com|Cue Biopharma (CUE) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|PDS Biotechnology Corporation - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|SONN (Sonnet BioTherapeutics Holdings, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan MAIABiotech.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Liminatus Pharma LLC (LIMN)|LVTX: Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|NextCure Corp - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Leap Therapeutics Inc (LPTX) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|INTS: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Sensei Biotherapeutics (SNSE) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|TOVX: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Gritstone bio (GRTS)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kineta Bio|NEXI: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan TSBX|VCNX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Harpoon Therapeutics, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan
